<DOC>
	<DOC>NCT01651247</DOC>
	<brief_summary>This study aims to analyse the serologic response to PCV-1 in the PEDIARIX® [GSK Biologicals' Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine] and KINRIX® (GSK Biologicals' Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) vaccine products. The samples have been collected at pre-determined time points from a subset of subjects who participated in selected studies [217744/085 and 213503/048] conducted in the United States.</brief_summary>
	<brief_title>Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing Vaccines</brief_title>
	<detailed_description>Serum samples from the previously conducted clinical trials (217744/085 and 213503/048) are used in this study.</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects enrolled previously in randomized, open and multicentre studies [217744/085; 213503/048]. Subjects aged 6 months to 6 years at last dose vaccinated with either DTaPHepBIPV vaccine or separately administered DTaP, HepB, and IPV vaccines or DTaPIPV vaccine or separately administered DTaP and IPV vaccines. Subjects for whom sufficient residual volume of the pre and post vaccination blood samples is available.</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Toddlers</keyword>
	<keyword>Retrospective</keyword>
	<keyword>Porcine circovirus type 1 (PCV-1)</keyword>
	<keyword>Infants</keyword>
	<keyword>Laboratory evaluations</keyword>
	<keyword>IPV</keyword>
</DOC>